# Use of S+Ketamine During Target-Controlled Intravenous Anaesthesia After Abdominal Hysterectomy

> **NCT03231683** · PHASE2 · COMPLETED · sponsor: **KK Women's and Children's Hospital** · enrollment: 90 (actual)

## Conditions studied

- Ketamine
- Anesthesia
- Morphine
- Hysterectomy

## Interventions

- **DRUG:** Esketamine
- **DRUG:** Saline
- **DRUG:** Remifentanil
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT03231683
- **Lead sponsor:** KK Women's and Children's Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2017-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03231683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03231683, "Use of S+Ketamine During Target-Controlled Intravenous Anaesthesia After Abdominal Hysterectomy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03231683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*